Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
Key Details
- 1AutoML model trained to classify pituitary macroadenomas vs. parasellar meningiomas on preoperative MRI.
- 2Achieved 97.55% overall accuracy, with sensitivities of 97% (macroadenoma) and 98.41% (meningioma), and specificities of 98.96% and 95.53%, respectively.
- 3External validation conducted on 959 additional MRI images.
- 4Model allows different confidence thresholds, aiding both community screening and tertiary centers.
- 5First reported use of AutoML for this specific neuro-oncology imaging task.
- 6The study published in Otolaryngology–Head and Neck Surgery (Dec 2025); presented at AAO-HNSF 2025.
Why It Matters
Accurate, non-invasive differentiation of similar-appearing benign brain tumors using MRI can improve preoperative planning, reduce surgical risks, and ensure patients receive optimal treatment. This demonstrates AutoML's potential to streamline diagnostic AI development and deployment in neuro-radiology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.